BRCA1 and BRCA2: different roles in a common pathway of genome protection

R Roy, J Chun, SN Powell - Nature Reviews Cancer, 2012 - nature.com
The proteins encoded by the two major breast cancer susceptibility genes, BRCA1 and
BRCA2, work in a common pathway of genome protection. However, the two proteins work …

Hallmarks of'BRCAness' in sporadic cancers

N Turner, A Tutt, A Ashworth - Nature reviews cancer, 2004 - nature.com
Germline mutations in the BRCA1, BRCA2 and Fanconi anaemia genes confer cancer
susceptibility, and the proteins encoded by these genes have distinct functions in related …

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

LA Carey, CM Perou, CA Livasy, LG Dressler… - Jama, 2006 - jamanetwork.com
ContextGene expression analysis has identified several breast cancer subtypes, including
basal-like, human epidermal growth factor receptor-2 positive/estrogen receptor negative …

World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs

TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …

[HTML][HTML] Triple-negative breast cancer—current status and future directions

O Gluz, C Liedtke, N Gottschalk, L Pusztai, U Nitz… - Annals of …, 2009 - Elsevier
Triple-negative breast cancer (TNBC) is defined by a lack of expression of both estrogen
and progesterone receptor as well as human epidermal growth factor receptor 2. It is …

[HTML][HTML] Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

JI Herschkowitz, K Simin, VJ Weigman, I Mikaelian… - Genome biology, 2007 - Springer
Background Although numerous mouse models of breast carcinomas have been developed,
we do not know the extent to which any faithfully represent clinically significant human …

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

M Esteller, JM Silva, G Dominguez… - JNCI: Journal of the …, 2000 - academic.oup.com
Background: Inherited mutations in the BRCA1 gene may be responsible for almost half of
inherited breast carcinomas. However, somatic (acquired) mutations in BRCA1 have not …

Triple-negative breast cancer: therapeutic options

S Cleator, W Heller, RC Coombes - The lancet oncology, 2007 - thelancet.com
Triple-negative breast cancers are defined by a lack of expression of oestrogen,
progesterone, and ERBB2 receptors. This subgroup accounts for 15% of all types of breast …

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

J Jonkers, R Meuwissen, H van der Gulden… - Nature …, 2001 - nature.com
Inheritance of one defective BRCA2 allele predisposes humans to breast cancer. To
establish a mouse model for BRCA2-associated breast cancer, we generated mouse …

Cancer suppression by the chromosome custodians, BRCA1 and BRCA2

AR Venkitaraman - Science, 2014 - science.org
Germline mutations in BRCA1 and BRCA2 predispose to common human malignancies,
most notably tumors of the breast and ovaries. The proteins encoded by these genes have …